Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by Vinny57on Oct 02, 2018 7:18pm
223 Views
Post# 28733346

???

???

Aphria Might List on the NYSE, But Investors Don’t Seem Happy

Aphria NYSE listing
 

On October 2nd, 2018, a Midas Letter reporter published an article. It hinted at a possible Aphria NYSE listing. At this point, it’s all speculation; however, reporter Benjamin Smith did give evidence to back up this claim.

For a Canadian cannabis stock, listing on the New York Stock Exchange is a good thing; so, why is the APHQF stock down nearly 10% today, hours after Smith went to press with his article?

Possible Aphria NYSE Listing on the Horizon

On Tuesday, Benjamin Smith wrote that Aphria, Inc. (TSX:APH) (OTCQB:APHQF) is in the midst of making a move similar to Canopy Growth (NYSE:CGC). According to the reporter, on September 28th, a Management Information Circular was filed by Aphria. In it, the Leamington-based company describes how its Board of Directors must meet specific US Securities Act requirements, like those in the NYSE Listed Company Manual. 

Enter Your E-mail Address To Subscribe

* indicates required
 
 

In the circular, Aphria talked about the New York Stock Exchange more than once. It was even in a section on Board independence. To Smith, this indicated that an Aphria NYSE listing could be on the horizon. 

But, as previously mentioned, the cannabis market doesn’t seem too pleased with the news. Granted, at least a dozen cannabis stocks are in the red zone Tuesday, but Aphria takes the cake.

Therefore, we wonder: do cannabis investors not want an Aphria NYSE listing to happen? Is that why the stock plunged today? Or, is it because the overall cannabis market is suffering?

>> OrganiGram Closes its Deal with CBD Producer Eviana Health Corp

The Aphria Share Price

According to Yahoo Finance, as of 2:40 p.m., Aphria is trading at $12.56, which puts the APHQF stock down 9.31%. 

The Takeaway

What do you think about Aphria listing on the NYSE? Remember that the company has not said anything to confirm this; it’s all speculation at the moment. However, if it ends up being true, and Aphria debuts like Canopy Growth on the NYSE, then I would expect the APH/APHQF stock to start seeing some green. Wouldn’t you?

Featured Image: Depositphotos/© .shock


Bullboard Posts